212 related articles for article (PubMed ID: 33094918)
21. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity.
Kuang Z; Wu J; Tan Y; Zhu G; Li J; Wu M
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979503
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Impact of Global Longitudinal Strain and NT-proBNP on Early Development of Cardiotoxicity in Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy.
Muckiene G; Vaitiekus D; Zaliaduonyte D; Zabiela V; Verseckaite-Costa R; Vaiciuliene D; Juozaityte E; Jurkevicius R
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241185
[No Abstract] [Full Text] [Related]
24. Cancer drug related cardiotoxicity during breast cancer treatment.
Giordano G; Spagnuolo A; Olivieri N; Corbo C; Campagna A; Spagnoletti I; Pennacchio RM; Campidoglio S; Pancione M; Palladino L; Villari B; Febbraro A
Expert Opin Drug Saf; 2016 Aug; 15(8):1063-74. PubMed ID: 27120499
[TBL] [Abstract][Full Text] [Related]
25. Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system.
Oleaga C; Riu A; Rothemund S; Lavado A; McAleer CW; Long CJ; Persaud K; Narasimhan NS; Tran M; Roles J; Carmona-Moran CA; Sasserath T; Elbrecht DH; Kumanchik L; Bridges LR; Martin C; Schnepper MT; Ekman G; Jackson M; Wang YI; Note R; Langer J; Teissier S; Hickman JJ
Biomaterials; 2018 Nov; 182():176-190. PubMed ID: 30130706
[TBL] [Abstract][Full Text] [Related]
26. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF
Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899
[TBL] [Abstract][Full Text] [Related]
27. Nutrition Modulation of Cardiotoxicity and Anticancer Efficacy Related to Doxorubicin Chemotherapy by Glutamine and ω-3 Polyunsaturated Fatty Acids.
Xue H; Ren W; Denkinger M; Schlotzer E; Wischmeyer PE
JPEN J Parenter Enteral Nutr; 2016 Jan; 40(1):52-66. PubMed ID: 25888676
[TBL] [Abstract][Full Text] [Related]
28. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
[TBL] [Abstract][Full Text] [Related]
29. Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast Cancer.
Yu AF; Singh JC; Wang R; Liu JE; Eaton A; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
Oncologist; 2017 Jun; 22(6):642-647. PubMed ID: 28341761
[TBL] [Abstract][Full Text] [Related]
30. Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology.
Mullen M; Wen Tan WL; Rhee JW; Wu JC
Heart Fail Clin; 2022 Jul; 18(3):335-347. PubMed ID: 35718410
[TBL] [Abstract][Full Text] [Related]
31. Global and regional patterns of longitudinal strain in screening for chemotherapy-induced cardiotoxicity.
Portugal G; Moura Branco L; Galrinho A; Mota Carmo M; Timóteo AT; Feliciano J; Abreu J; Duarte Oliveira S; Batarda L; Cruz Ferreira R
Rev Port Cardiol; 2017 Jan; 36(1):9-15. PubMed ID: 27955938
[TBL] [Abstract][Full Text] [Related]
32. Role of Cardiac Biomarkers in Monitoring Cardiotoxicity in Chemotherapy Patients.
Battisha A; Sawalha K; Obeidat Y; Patel B
Crit Pathw Cardiol; 2023 Sep; 22(3):83-87. PubMed ID: 37607037
[TBL] [Abstract][Full Text] [Related]
33. Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer.
Kitani T; Ong SG; Lam CK; Rhee JW; Zhang JZ; Oikonomopoulos A; Ma N; Tian L; Lee J; Telli ML; Witteles RM; Sharma A; Sayed N; Wu JC
Circulation; 2019 May; 139(21):2451-2465. PubMed ID: 30866650
[TBL] [Abstract][Full Text] [Related]
34. microRNA miR-133a as a Biomarker for Doxorubicin-Induced Cardiotoxicity in Women with Breast Cancer: A Signaling Pathway Investigation.
Alves MT; da Conceição IMCA; de Oliveira AN; Oliveira HHM; Soares CE; de Paula Sabino A; Silva LM; Simões R; Luizon MR; Gomes KB
Cardiovasc Toxicol; 2022 Jul; 22(7):655-662. PubMed ID: 35524907
[TBL] [Abstract][Full Text] [Related]
35. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
[TBL] [Abstract][Full Text] [Related]
36. Predicting human cardiac QT alterations and pro-arrhythmic effects of compounds with a 3D beating heart-on-chip platform.
Visone R; Lozano-Juan F; Marzorati S; Rivolta MW; Pesenti E; Redaelli A; Sassi R; Rasponi M; Occhetta P
Toxicol Sci; 2023 Jan; 191(1):47-60. PubMed ID: 36226800
[TBL] [Abstract][Full Text] [Related]
37. Leucine zipper protein 1 prevents doxorubicin-induced cardiotoxicity in mice.
Fan D; Jin Z; Cao J; Li Y; He T; Zhang W; Peng L; Liu H; Wu X; Chen M; Fan Y; He B; Yu W; Wang H; Hu X; Lu Z
Redox Biol; 2023 Aug; 64():102780. PubMed ID: 37354826
[TBL] [Abstract][Full Text] [Related]
38. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Wang Z; Yang Y; Lan C
Phytomedicine; 2023 Aug; 117():154922. PubMed ID: 37321078
[TBL] [Abstract][Full Text] [Related]
39. Doxorubicin-induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIα to IIβ in human stem cell derived cardiomyocytes.
Cui N; Wu F; Lu WJ; Bai R; Ke B; Liu T; Li L; Lan F; Cui M
J Cell Mol Med; 2019 Jul; 23(7):4627-4639. PubMed ID: 31106979
[TBL] [Abstract][Full Text] [Related]
40. Potential usefulness of diastolic parameters measured by strain imaging echocardiography in the early prediction of chemotherapy-induced cardiotoxicity.
Hernandez-Suarez DF; López-Candales A
Med Hypotheses; 2017 Apr; 101():30-32. PubMed ID: 28351486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
